Last month, Tandem Diabetes Care (NSDQ:TNDM) announced that the FDA approved its t:slim X2 insulin pump integrated with Dexcom‘s (NSDQ:DXCM) G5 mobile continuous glucose monitor.
The San Diego, Calif.-based company made the software available to its current t:slim X2 pump users at no additional cost, enabling them to add CGM-integration to their existing devices.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem touts adoption of CGM update to t:slim X2 insulin pump appeared first on MassDevice.
from MassDevice http://ift.tt/2yaToIH
Cap comentari:
Publica un comentari a l'entrada